|1||NCT01032408||Completed||Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection||
||154||All||18 Years to 60 Years (Adult)||NCT01032408||V111_14TP||April 2010||September 2011||July 2012||December 15, 2009||June 5, 2013||
|2||NCT00783380||Completed||Influenza Vaccination in Immunocompromized Patients||
||Other / Industry||
||304||All||18 Years and older (Adult, Senior)||NCT00783380||KEK No 805 (EK 151/03)||October 2005||July 2006||March 2008||October 31, 2008||November 3, 2008||
† Study has passed its completion date and status has not been verified in more than two years.